Pyrrolopyridine-2-carboxylic acid hydrazides
US7884112B2 · kind B2 · utility
0Cited by
26References
15Claims
0Family size
Inventors
Key dates
| Filing date | Nov 5, 2007 |
| Grant date | Feb 8, 2011 |
| Priority date | — |
| Expiry date | May 28, 2029 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P35/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Compounds of Formula (I) or pharmaceutically acceptable salts thereof, are inhibitors of glycogen phosphorylase and are useful in the prophylactic or therapeutic treatment of diabetes, hyperglycemia, hypercholesterolemia, hyperinsulinemia, hyperlipidemia, hypertension, atherosclerosis or tissue ischemia e.g. myocardial ischemia, or as cardioprotectants or inhibitors of abnormal cell growth.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.